These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19213942)

  • 1. PDGF-A, -C, and -D but not PDGF-B increase TGF-beta1 and chronic rejection in rat cardiac allografts.
    Tuuminen R; Nykänen AI; Krebs R; Soronen J; Pajusola K; Keränen MA; Koskinen PK; Alitalo K; Lemström KB
    Arterioscler Thromb Vasc Biol; 2009 May; 29(5):691-8. PubMed ID: 19213942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of platelet-derived growth factor ligands in rat cardiac allograft vasculopathy and fibrosis.
    Tuuminen R; Nykänen A; Keränen MA; Krebs R; Alitalo K; Koskinen PK; Lemström KB
    Transplant Proc; 2006 Dec; 38(10):3271-3. PubMed ID: 17175246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis.
    Watschinger B; Sayegh MH; Hancock WW; Russell ME
    Am J Pathol; 1995 May; 146(5):1065-72. PubMed ID: 7747801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.
    Nykänen AI; Sandelin H; Krebs R; Keränen MA; Tuuminen R; Kärpänen T; Wu Y; Pytowski B; Koskinen PK; Ylä-Herttuala S; Alitalo K; Lemström KB
    Circulation; 2010 Mar; 121(12):1413-22. PubMed ID: 20231530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Oct; 38(8):2719-21. PubMed ID: 17098049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor necrosis factor-alpha attenuates myocardial remodeling in rat cardiac allografts.
    Sihvola RK; Koskinen PK; Pulkkinen VP; Tikkanen JM; Lemström KB
    J Heart Lung Transplant; 2006 May; 25(5):569-78. PubMed ID: 16678037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGFR-1 and -2 regulate inflammation, myocardial angiogenesis, and arteriosclerosis in chronically rejecting cardiac allografts.
    Raisky O; Nykänen AI; Krebs R; Hollmén M; Keränen MA; Tikkanen JM; Sihvola R; Alhonen L; Salven P; Wu Y; Hicklin DJ; Alitalo K; Koskinen PK; Lemström KB
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):819-25. PubMed ID: 17290032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for recipient derived fibroblast recruitment and activation during the development of chronic cardiac allograft rejection.
    Wu GD; Tuan TL; Bowdish ME; Jin YS; Starnes VA; Cramer DV; Barr ML
    Transplantation; 2003 Aug; 76(3):609-14. PubMed ID: 12923453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor, transforming growth factor-beta, and connective tissue growth factor in a porcine bronchial model of obliterative bronchiolitis.
    Alho HS; Maasilta PK; Vainikka T; Salminen US
    Exp Lung Res; 2007 Aug; 33(6):303-20. PubMed ID: 17694440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of platelet-derived growth factor in rat cardiac allograft vasculopathy and fibrosis.
    Song G; Fang Y; Wang X; Wu S; Song H
    Transplant Proc; 2008 Oct; 40(8):2716-9. PubMed ID: 18929844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.
    Nykänen AI; Krebs R; Tikkanen JM; Raisky O; Sihvola R; Wood J; Koskinen PK; Lemström KB
    Transplantation; 2005 Jan; 79(2):182-9. PubMed ID: 15665766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation of alternatively spliced platelet-derived growth factor-A chain and correlation with expression of PDGF receptor-alpha in human cardiac allografts.
    Zhao XM; Frist WH; Yeoh TK; Miller GG
    Transplantation; 1995 Feb; 59(4):605-11. PubMed ID: 7878765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antisense TGF-beta 1 transfection decreases acute and chronic rejection in allografts].
    Redaelli CA; Schilling MK; Hullett DA; Büchler MW; Sollinger HW
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):699-704. PubMed ID: 14518344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A.
    Thieringer F; Maass T; Czochra P; Klopcic B; Conrad I; Friebe D; Schirmacher P; Lohse AW; Blessing M; Galle PR; Teufel A; Kanzler S
    Gene; 2008 Oct; 423(1):23-8. PubMed ID: 18598744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of transforming growth factor-beta during cardiac allograft rejection.
    Waltenberger J; Wanders A; Fellström B; Miyazono K; Heldin CH; Funa K
    J Immunol; 1993 Jul; 151(2):1147-57. PubMed ID: 8335896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk of endothelin-1 and platelet-derived growth factor in cardiac allograft arteriosclerosis.
    Sihvola RK; Pulkkinen VP; Koskinen PK; Lemström KB
    J Am Coll Cardiol; 2002 Feb; 39(4):710-7. PubMed ID: 11849873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy.
    Yamaura K; Ito K; Tsukioka K; Wada Y; Makiuchi A; Sakaguchi M; Akashima T; Fujimori M; Sawa Y; Morishita R; Matsumoto K; Nakamura T; Suzuki J; Amano J; Isobe M
    Circulation; 2004 Sep; 110(12):1650-7. PubMed ID: 15364799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts.
    Spriewald BM; Ensminger SM; Billing JS; Morris PJ; Wood KJ
    Transplantation; 2003 Oct; 76(7):1105-11. PubMed ID: 14557761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
    Siddiqui I; Khan ZA; Lian D; Jiang J; Zhong R; Garcia B; Chakrabarti S
    Transplantation; 2006 Aug; 82(3):406-14. PubMed ID: 16906041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.